IP Library › Granted Patent US 11,419,759
Granted Patent B2
US 11,419,759 · App. 16/877,308 · Granted Aug 23, 2022

Fluid exchange apparatus for expandable port delivery system and methods of use

Inventors: Kevin W. Sacherman (Palo Alto, CA); Randolph E. Campbell (Redwood City, CA); Darren Doud (Los Altos, CA); Kathleen Cogan Farinas (Los Altos, CA)
Assignee: ForSight Vision4, Inc.
A61F9/0017A61M31/002A61M2202/02A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,419,759
App. No.
16/877,308
Granted
Aug 23, 2022
Kind
B2
Abstract

A device for injecting a therapeutic agent into an ocular implant at least partially implanted in an eye including an injection lumen providing a pathway for injecting the therapeutic agent into the implant; an outlet lumen providing a pathway for pre-existing fluid in the ocular implant to exit the implant; and a collection chamber fluidly coupled to the outlet lumen that provides a first fluid outflow resistance and a second fluid outflow resistance. The first fluid outflow resistance is lower than a first resistance to outflow of the implant. The second fluid outflow resistance is greater than a force imparted onto the implant by intraocular pressure of the eye. Injection of therapeutic agent into the implant via the injection lumen causes the pre-existing fluid to exit the implant and enter the collection chamber via the outlet lumen and causes a second pre-existing fluid to displace from the collection chamber.

Claims (27)

1. A device for injecting a therapeutic agent into an ocular implant, the implant being at least partially implanted in an eye, the implant further providing at least a first resistance to outflow of therapeutic agent into the eye, the device comprising:

an injection lumen configured to provide a pathway for injecting the therapeutic agent into the ocular implant;

an outlet lumen configured to provide a pathway through which pre-existing fluid in the ocular implant exits the ocular implant; and

a collection chamber fluidly coupled to the outlet lumen and operatively coupled to a first porous structure positioned within an annular element positioned near an upper end of the collection chamber forming a fixed upper limit of the collection chamber, the collection chamber configured to receive the pre-existing fluid that exits the ocular implant via the outlet lumen,

wherein the first porous structure of the collection chamber provides a first fluid outflow resistance to gas outflow and a second fluid outflow resistance to liquid outflow, wherein the first fluid outflow resistance is lower than the first resistance to outflow of the implant, and the second fluid outflow resistance is greater than a force imparted onto the implant by intraocular pressure of the eye, and

wherein injection of therapeutic agent into the ocular implant via the injection lumen causes the pre-existing fluid to exit the ocular implant and enter the collection chamber via the outlet lumen and causes a second pre-existing fluid to displace from the collection chamber.

2. The device of claim 1 , wherein the implant is expandable once implanted in the eye from a first, collapsed configuration to a second, enlarged configuration.

3. The device of claim 1 , wherein the implant comprises a second porous structure that provides the first resistance to outflow.

4. The device of claim 3 , wherein the first fluid outflow resistance of the first porous structure of the collection chamber is less than the first resistance provided by the second porous structure of the implant, and the second fluid outflow resistance of the first porous structure of the collection chamber is greater than the first resistance of the implant.

5. The device of claim 1 , wherein the second pre-existing fluid is a gas.

6. The device of claim 5 , wherein the gas is air.

7. The device of claim 6 , wherein the air is under vacuum.

8. The device of claim 1 , wherein the second pre-existing fluid is displaced from the collection chamber via a vent.

9. The device of claim 1 , wherein the second pre-existing fluid is displaced from the collection chamber via a valve.

10. The device of claim 3 , wherein the implant is expandable once implanted in the eye from a first, collapsed configuration to a second, enlarged configuration, wherein the first porous structure of the collection chamber prevents collapse of the implant away from the second, enlarged configuration after filling.

11. The device of claim 3 , wherein the first porous structure of the collection chamber is a hydrophobic membrane, a fabric, a porous fabric, a semipermeable membrane, an air permeable material, a moisture vapor transfer waterproof fabric, a hydrophilic porous material, or a porous sintered material.

12. The device of claim 3 , wherein the collection chamber is concentric with a longitudinal axis of the injection lumen.

13. A device for injecting a therapeutic agent into an ocular implant, the implant being at least partially implanted in an eye, the implant further providing at least a first resistance to outflow of therapeutic agent into the eye, the device comprising:

an injection lumen configured to provide a pathway for injecting the therapeutic agent into the ocular implant;

an outlet lumen configured to provide a pathway through which pre-existing fluid in the ocular implant exits the ocular implant; and

a collection chamber fluidly coupled to the outlet lumen and operatively coupled to a first porous structure, the collection chamber configured to receive the pre-existing fluid that exits the ocular implant via the outlet lumen,

wherein the first porous structure of the collection chamber provides a first fluid outflow resistance to gas outflow and a second fluid outflow resistance to liquid outflow, wherein the first fluid outflow resistance is lower than the first resistance to outflow of the implant, and the second fluid outflow resistance is greater than a force imparted onto the implant by intraocular pressure of the eye, and

wherein injection of therapeutic agent into the ocular implant via the injection lumen causes the pre-existing fluid to exit the ocular implant and enter the collection chamber via the outlet lumen and causes a second pre-existing fluid to displace from the collection chamber, wherein the collection chamber is a coiled tubular structure providing a uniform fill pattern that minimizes trapping of the second pre-existing fluid displaced from the collection chamber.

14. The device of claim 13 , wherein the collection chamber is offset relative to a longitudinal axis of the injection lumen.

15. The device of claim 14 , wherein the coiled tubular structure extends between an opening into the tubular collection chamber and terminates at the first porous structure.

16. The device of claim 15 , wherein the coiled tubular structure has a uniform inner diameter over a length of the coiled tubular structure.

17. The device of claim 15 , where the coiled tubular structure has an inner diameter that enlarges proximally to a second inner diameter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2020
From: CAMPBELL, RANDOLPH E.; SACHERMAN, KEVIN W.; FARINAS, KATHLEEN COGAN; DOUD, DARREN
To: FORSIGHT VISION4, INC.
Reel/Frame 053525/0646 →
Continuity (3)
Continuation PCTUS2018061262 · Nov 15, 2018
Provisional Application 62589377 · Nov 21, 2017
Related Publication 20200337897A1 · Oct 29, 2020